July 25, 2014 3:25 AM ET


Company Overview of Biscayne Pharmaceuticals, Inc.

Company Overview

Biscayne Pharmaceuticals, Inc. operates as a biopharmaceutical company that develops therapies based on growth hormone-releasing hormone (GHRH) analogs. The compounds include GHRH antagonists in development for the treatment of cancer, including castrate-resistant prostate cancer, and GHRH agonists for the repair of cardiac damage in heart disease patients. The company was incorporated in 2012 and is headquartered in Miami, Florida.

4770 Biscayne Boulevard

Suite 660

Miami, FL 33137

United States

Founded in 2012



Key Executives for Biscayne Pharmaceuticals, Inc.

Chief Executive Officer and Chairman
Age: 39
Compensation as of Fiscal Year 2014.

Biscayne Pharmaceuticals, Inc. Key Developments

Biscayne Pharmaceuticals, Inc. Presents at 7th Annual Early Stage Capital Conference, May-15-2014

Biscayne Pharmaceuticals, Inc. Presents at 7th Annual Early Stage Capital Conference, May-15-2014 . Venue: Reunion Resort, 7593 Gathering Drive, Kissimmee, FL 34747, United States.

Similar Private Companies By Industry

Company Name Region
NGM Biopharmaceuticals, Inc. United States
Invent Pharmaceuticals, Inc. United States
Anesta Corp. United States
Protometrix Inc. United States
SphynKx Therapeutics LLC United States

Recent Private Companies Transactions

Private Placement
April 11, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Biscayne Pharmaceuticals, Inc., please visit biscaynepharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.